San Jose, CA, United States of America

Sarkiz D Issakani


Average Co-Inventor Count = 4.3

ph-index = 4

Forward Citations = 118(Granted Patents)


Location History:

  • San Jose, CA (US) (2004 - 2011)
  • Redwood City, CA (US) (2009 - 2021)

Company Filing History:


Years Active: 2004-2021

Loading Chart...
12 patents (USPTO):Explore Patents

Title: The Innovative Mind of Sarkiz D. Issakani

Introduction

Sarkiz D. Issakani, a prominent inventor based in San Jose, CA, has made significant contributions to the field of pharmaceuticals with a total of 12 patents to his name. His work focuses on developing novel compounds that have the potential to impact various medical conditions positively.

Latest Patents

Among his latest innovations, Issakani has patented compounds such as direct AMPK activators. These benzimidazole compounds are designed to activate the AMPK pathway, which could be utilized in treatments for diseases linked to metabolic disorders. Another noteworthy invention includes ubiquitination inhibitors, sulfonamidoquinoline compounds that block the degradation of tumor suppressors and may offer new avenues for cancer treatment.

Career Highlights

Sarkiz D. Issakani is currently employed at Rigel Pharmaceuticals, Incorporated, where he continues to push the boundaries of pharmaceutical research and development. His innovative approach has helped the company explore new treatment modalities aimed at better health outcomes for patients.

Collaborations

Issakani's work often involves collaboration with talented colleagues, including Jianing Huang and Julie Sheung. Together, they share knowledge and expertise that enhance their collective impact in the industry, fostering an environment of innovation and creativity.

Conclusion

Sarkiz D. Issakani is not only an accomplished inventor but also a driving force behind groundbreaking research in pharmaceuticals. His ongoing efforts are set to pave the way for advancements in medical treatments, showcasing the importance of innovation in addressing complex health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…